News Focus
News Focus
Followers 52
Posts 14371
Boards Moderated 0
Alias Born 06/15/2014

Re: JRoon71 post# 446930

Wednesday, 03/25/2026 1:16:18 PM

Wednesday, March 25, 2026 1:16:18 PM

Post# of 447903
Agreed with the caveat that we need to know a lot more about not only the new formulation, but how insurance companies will handle it and how docs and patients may or may not try to subvert it with GV. Yes, I know less API so the new formulation costs less. But that costs less is to Amarin and not necessarily what patients would pay. Again I could be all wet with this type of speculation but it just shows that we know so little about it and its ramifications in the marketplace.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News